We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$617M
(+40%)
Cap. Flow
+$399M
Cap. Flow
% of AUM
18.35%
Top 10 Holdings %
Top 10 Hldgs %
22.83%
Holding
3,224
New
565
Increased
1,310
Reduced
679
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$52.4M |
| 2 |
Panagram BBB-B CLO ETF
CLOZ
|
+$37.6M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.3M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$24.4M |
| 5 |
Merck
MRK
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.9M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$20.7M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$19.4M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.2M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 4.24% |
| 3 | Healthcare | 3.21% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
RxSight
RXST
$245M
| $3.39K | ﹤0.01% |
261
+236
| +944% | +$3.55K |
|
2377
Scotiabank
BNS
$108B
| $3.37K | ﹤0.01% |
+61
| New | +$3.1K |
|
|
ACLX
2378
DELISTED
Arcellx
ACLX
| $3.36K | ﹤0.01% |
51
+40
| +364% | +$2.49K |
|
2379
Calamos Strategic Total Return Fund
CSQ
$3.33B
| $3.36K | ﹤0.01% |
184
| – | – |
|
2380
Novanta
NOVT
$5.98B
| $3.35K | ﹤0.01% |
26
-56
| -68% | -$6.82K |
|
2381
Evolution Petroleum
EPM
$127M
| $3.35K | ﹤0.01% |
712
+393
| +123% | +$1.78K |
|
2382
Glacier Bancorp
GBCI
$6.37B
| $3.34K | ﹤0.01% |
77
-25
| -25% | -$1.04K |
|
2383
Hope Bancorp
HOPE
$1.79B
| $3.34K | ﹤0.01% |
311
-143
| -31% | -$1.44K |
|
2384
Innoviva
INVA
$1.56B
| $3.33K | ﹤0.01% |
166
+155
| +1,409% | +$2.98K |
|
2385
PENN Entertainment
PENN
$2.73B
| $3.32K | ﹤0.01% |
186
+112
| +151% | +$1.76K |
|
2386
First Trust Nasdaq Bank ETF
FTXO
$312M
| $3.3K | ﹤0.01% |
100
| – | – |
|
|
PARA
2387
DELISTED
Paramount Global Class B
PARA
| $3.29K | ﹤0.01% |
255
| – | – |
|
2388
Xperi
XPER
$341M
| $3.27K | ﹤0.01% |
+414
| New | +$3.12K |
|
|
CRWV
2389
CoreWeave
CRWV
$47.3B
| $3.26K | ﹤0.01% |
+20
| New | +$1.84K |
|
2390
Anika Therapeutics
ANIK
$268M
| $3.26K | ﹤0.01% |
+308
| New | +$3.89K |
|
|
DFTX
2391
Definium Therapeutics
DFTX
$5.93B
| $3.25K | ﹤0.01% |
501
+237
| +90% | +$1.56K |
|
2392
Beazer Homes USA
BZH
$919M
| $3.24K | ﹤0.01% |
145
+99
| +215% | +$2.06K |
|
2393
Community Bank
CBU
$3.45B
| $3.24K | ﹤0.01% |
57
+2
| +4% | +$111 |
|
2394
Compass
COMP
$9.29B
| $3.24K | ﹤0.01% |
516
-3,086
| -86% | -$21.1K |
|
2395
Liberty Global Class C
LBTYK
$3.59B
| $3.24K | ﹤0.01% |
314
-1,062
| -77% | -$11K |
|
2396
Helen of Troy
HELE
$675M
| $3.24K | ﹤0.01% |
+114
| New | +$3.5K |
|
2397
PLDT
PHI
$4.32B
| $3.24K | ﹤0.01% |
+149
| New | +$3.36K |
|
2398
Albany International
AIN
$1.73B
| $3.23K | ﹤0.01% |
46
-5
| -10% | -$332 |
|
2399
FTAI Aviation
FTAI
$22.9B
| $3.22K | ﹤0.01% |
+28
| New | +$3.13K |
|
2400
Select Water Solutions
WTTR
$2.57B
| $3.21K | ﹤0.01% |
+372
| New | +$3.21K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Arax Advisory Partners held 3,224 positions worth $2.18B, up 40% from $1.56B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Arax Advisory Partners deployed $399M of net new capital in Q2 2025, opening 565 new positions and adding to 1,310 existing holdings. Its largest new stake was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $21.9M trimmed.
- Arax Advisory Partners's largest Q2 2025 buy was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
- Arax Advisory Partners added most to Axon Enterprise in Q2 2025, an estimated $52.4M increase.
- Arax Advisory Partners's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $21.9M.
- Arax Advisory Partners fully exited YieldMax MSTR Option Income Strategy ETF in Q2 2025, selling an estimated $102K.
- Arax Advisory Partners's ten largest holdings make up 23% of its $2.18B portfolio in Q2 2025.
- Arax Advisory Partners opened 565 new positions and closed 193 in Q2 2025.
- Arax Advisory Partners's portfolio value rose 40% quarter-over-quarter to $2.18B.
Based on Arax Advisory Partners's 13F filing for Q2 2025, filed 12 Aug 2025.